Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1394799

GTEX

aa13d198-b332-5a33-89d3-a5ab47e8a620

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Female

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.123
  • WNT_BETA_CATENIN_SIGNALING+0.115
  • PI3K_AKT_MTOR_SIGNALING+0.093
  • DNA_REPAIR+0.071
  • UNFOLDED_PROTEIN_RESPONSE+0.064
  • UV_RESPONSE_UP+0.044
  • MITOTIC_SPINDLE+0.018
  • MYC_TARGETS_V2+0.007
  • ANDROGEN_RESPONSE+0.000
  • PROTEIN_SECRETION-0.014

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.579
  • INTERFERON_GAMMA_RESPONSE-0.470
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.439
  • INFLAMMATORY_RESPONSE-0.430
  • ALLOGRAFT_REJECTION-0.421
  • KRAS_SIGNALING_UP-0.393
  • ANGIOGENESIS-0.386
  • COAGULATION-0.370
  • IL6_JAK_STAT3_SIGNALING-0.353
  • APOPTOSIS-0.329

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1361736
brain-umap@2
GTEX0.950
2SRR1471417
brain-umap@2
GTEX0.950
3SRR1490568
brain-umap@2
GTEX0.950
4SRR1387072
brain-umap@2
GTEX0.949
5SRR1464305
brain-umap@2
GTEX0.949
6SRR1359367
brain-umap@2
GTEX0.948
7SRR820468
brain-umap@2
GTEX0.946
8SRR1331944
brain-umap@2
GTEX0.946
9SRR1335377
brain-umap@2
GTEX0.946
10SRR1440119
brain-umap@2
GTEX0.945

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.123Remibrutinib— uncovered
WNT_BETA_CATENIN_SIGNALING0.115Inavolisib— uncovered
PI3K_AKT_MTOR_SIGNALING0.093Inavolisib— uncovered
DNA_REPAIR0.071Idelalisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.064Idelalisib— uncovered
UV_RESPONSE_UP0.044Idelalisib— uncovered
MITOTIC_SPINDLE0.018Inavolisib— uncovered
MYC_TARGETS_V20.007Idelalisib— uncovered